Skip to main
TFX
TFX logo

Teleflex (TFX) Stock Forecast & Price Target

Teleflex (TFX) Analyst Ratings

Based on 24 analyst ratings
Buy
Strong Buy 17%
Buy 33%
Hold 46%
Sell 4%
Strong Sell 0%

Bulls say

Teleflex's financial outlook is supported by a projected sales growth rate of approximately 6% off a nearly $1 billion base in its interventional business, indicating a strong market position. Additionally, the company's strategic focus on cost reduction and the introduction of new product lines are expected to enhance operating margins while facilitating double-digit earnings growth. With a bull case scenario projecting organic revenue growth between 4-6% and the potential for further acquisitions, Teleflex stands to benefit from favorable shifts towards higher growth and higher margin products in the coming years.

Bears say

Teleflex's recent performance has raised significant concerns, particularly following its fourth-quarter 2024 results, which revealed a substantial drop in share value and a disappointing revenue guidance for 2025 that fell well below market expectations. The company's forecasted revenue growth of only 1.0-2.0% year-over-year contrasts sharply with the Street's projection of 4.5%, indicating potential challenges in key segments, notably the UroLift product line and overall price pressures in office settings. Additionally, the planned acquisition of Biotronik's Vascular Intervention business for approximately $820 million, coupled with the division of the company into two parts, raises further apprehension regarding the strategic direction and financial implications for Teleflex going forward.

Teleflex (TFX) has been analyzed by 24 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 33% recommend Buy, 46% suggest Holding, 4% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teleflex and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teleflex (TFX) Forecast

Analysts have given Teleflex (TFX) a Buy based on their latest research and market trends.

According to 24 analysts, Teleflex (TFX) has a Buy consensus rating as of Jul 23, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $250.29, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $250.29, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teleflex (TFX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.